Huayi Pharmaceuticals (Anhui) Co., Ltd. is the first company passing European certification in Anhui. As a contract development and manufacturing organization (CDMO) dedicated to providing various dosage forms for Chinese and European markets, the company has been granted with EU GMP certificate in August 2010 after passing the GMP inspection by Medicines and Healthcare Products Regulatory Agency (MHRA). The certificate has been updated three times after re-inspections by MHRA. The company also has passed the quality inspections by more than 200 companies at home and abroad including Teva, KrKa and Novartis etc. and has passed several GMP compliance inspections by Chinese authorities (NMPA).

Since its establishment, the company has been providing joint venture cooperation, multiple dosage forms pharmaceutical development, commercial production on a contract basis, chemical synthesis research, and drug clinical testing services for research institutions and pharmaceutical sales enterprises etc. at home and abroad and has gradually built an open CDMO platform for international markets, which is dedicated in R&D of multiple dosage forms and focused on manufacturing of oral preparations, providing chemical synthesis as supplementary service.

Adhering to the corporate value of “create value and benefit for the world” and corporate spirit of “keep pragmatic and innovative all the time”, Huayi is fully engaged in providing customers with pharmaceutical development and production services of high efficiency, high quality and controllable cost and making high quality drugs at affordable cost. Huayi sincerely looks forward to cooperating with partners from all over the world on the pharmaceutical development, contract manufacture, MA application in both China and Europe and joint venture cooperation and developing both the international and domestic markets.